Nouvelle-Zélande’s Innovative Approach to Stem Cell Treatment for Primary Pulmonary Hypertension
Nouvelle-Zélande’s pioneering approach to treating primary pulmonary hypertension (PPH) with stem cell therapy offers a beacon of hope for patients with this debilitating condition. En exploitant le potentiel régénératif des cellules souches, researchers aim to repair damaged lung tissue and restore pulmonary function, potentially alleviating the life-threatening symptoms of PPH. This innovative strategy represents a significant step forward in the fight against this rare and devastating disease.